Most Read Articles
Pearl Toh, 2 days ago
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Audrey Abella, 4 days ago
Extremes of sleep duration (≤5 or ≥10 hours/day), which is a known mortality risk factor in the general population, may increase absolute mortality in adults with type 2 diabetes (T2D), a prospective study has shown.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Roshini Claire Anthony, 12 Oct 2020

Insulin icodec, an in-development basal insulin analogue administered once weekly, was as effective as once-daily insulin glargine in patients with type 2 diabetes (T2D) insufficiently controlled with metformin with or without a DPP-4* inhibitor, according to a phase II trial presented at EASD 2020.

Sexual dysfunction common among Parkinson’s disease patients

09 Oct 2020
A new method of using eye tests may help to detect Parkinson’s disease before the first symptoms appear

Patients with Parkinson’s disease (PD) usually suffer from sexual dysfunction, a recent study has found.

The researchers conducted a multicentre observational study including 203 PD patients (mean age, 68.36±8.5 years; 113 males). A semi-structured interview using a 40-item ad hoc questionnaire was performed to evaluate participant sociodemographic, illness perception, and sexuality. The International Index of Erectile Function and Female Sexual Function Index were also used.

While most (85 percent) of the PD patients were in a stable relationship, only 18.72 percent and 38.2 percent were satisfied and very satisfied with the relationship, respectively. Fifty-seven percent said that the disease affected their sexual life, mostly through reducing sexual desire and the frequency of intercourse.

Around 60 percent (n=120) of the participants had sexual dysfunction, which was more common among men (p=0.04) and older participants. Those with comorbidities, particularly diabetes mellitus (p<0.01), were likewise significantly more likely to report sexual dysfunction (p=0.04).

While most of the participants (35.46 percent) noted that they were calm and relaxed when dealing with sexual intercourse, 30.06 percent harboured negative moods, such as frustration, anxiety, and anger. The remaining 17.24 percent were indifferent towards sex.

“Clinicians dealing with neurological disorders should pay more attention to sexual issues, as discussing and treating sexual problems enters the framework of a holistic approach, which is mandatory in chronic illness, including PD,” the researchers said.

Future research is needed to validate the current findings, as well as to improve the management of sexual dysfunction among PD patients.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 2 days ago
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Audrey Abella, 4 days ago
Extremes of sleep duration (≤5 or ≥10 hours/day), which is a known mortality risk factor in the general population, may increase absolute mortality in adults with type 2 diabetes (T2D), a prospective study has shown.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Roshini Claire Anthony, 12 Oct 2020

Insulin icodec, an in-development basal insulin analogue administered once weekly, was as effective as once-daily insulin glargine in patients with type 2 diabetes (T2D) insufficiently controlled with metformin with or without a DPP-4* inhibitor, according to a phase II trial presented at EASD 2020.